Skip to main content

Table 4 Multilevel multivariate models for PHYS and PSYS of CHF-PRO

From: Assessment of chronic disease self-management in patients with chronic heart failure based on the MCID of patient-reported outcomes by the multilevel model

Parameters

Model 1

Model 2

Model 3

PHY

PSY

PHY

PSY

PHY

PSY

Fixed effects

  

Intercept

68.18 (0.26)

97.02 (0.25)

58.68 (0.51)

88.43 (0.64)

63.04 (1.74)

77.73 (1.77)

Time

  

4.16 (0.17)*

3.71 (0.19)*

2.27 (0.18)*

2.15 (0.21)*

Age

    

− 0.12 (0.01)*

− 0.02 (0.01)*

Female

    

− 1.05 (0.40)*

− 1.36 (0.36)*

NYHA

    

− 3.10 (0.23)*

− 0.76 (0.22)*

CCI

    

− 0.43 (0.16)*

− 0.30 (0.14)*

ACEI or ARB

    

− 0.42 (0.45)

− 1.00 (0.40)*

Regular schedule

    

1.24 (0.22)*

1.46 (0.23)*

Low sodium diet

    

0.86 (0.19)*

0.76 (0.20)*

Avoid over-eating

    

1.96 (0.26)*

2.63 (0.28)*

Exercises

    

1.18 (0.14)*

0.55 (0.14)*

Random effects

Level 3 (subjects)

 (Intercept)

 

13.85 (2.35)

 

67.50 (9.42)*

 

68.25 (7.96)*

 (Intercept)

 

1.81 (1.85)

 

38.57 (8.90)*

 

49.07 (8.02)*

 (Intercept)

 

10.50 (2.29)

 

148.65 (13.84)*

 

159.18 (13.40)*

 (Time)

   

2.91 (1.01)*

 

4.47 (0.87)*

 (Time)

   

8.58 (1.27)*

 

10.90 (1.25)*

Level 2 (time point)

 (Intercept)

 

78.32 (2.99)

 

47.40 (2.19)*

 

34.55 (1.60)*

 (Intercept)

 

54.76 (2.65)

 

28.19 (1.77)*

 

17.02 (1.28)*

 (Intercept)

 

85.00 (3.24)

 

46.88 (2.12)*

 

36.62 (1.67)*

− 2 Log likelihood

 

27,286.37

 

26,155.51

 

25,458.50

  1. ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor antagonist, CCI Charlson Comorbidity Index CHF-PRO chronic heart failure—patient reported outcome, NYHA New York Heart Association functional class, PHYS physical scores, PSYS psychological scores